55 results
8-K
EX-1.1
RVNC
Revance Therapeutics Inc
5 Mar 24
Other Events
5:08pm
with the Underwriter Information (as defined in Section 9(b)).
(c) General Disclosure Package. The Pricing Prospectus, as supplemented by the information listed … on Schedule II(b) hereto, taken together (collectively, the “General Disclosure Package”) as of the Applicable Time did not, and as of the Time of Delivery
8-K
EX-99.2
tvedb9z
19 Sep 23
Revance Provides Corporate Update at Investor Day
9:01am
8-K
EX-99.1
e5hkafz4d83y f3h
8 Nov 22
Provides Corporate Update
4:06pm
8-K
EX-1.1
g897 6y4qpmi
13 Sep 22
Other Events
9:55pm
8-K
EX-99.1
nmjptgm2qe1wa1qu0
28 Feb 22
Provides Corporate Update
4:10pm
8-K
l32v n1i3vl4gx
18 Jan 22
Other Events
4:07pm